Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea
· Delayed Price · Currency is KRW 4,325.00
+30.00 (0.70%)
At close: Dec 5, 2025
Genesystem Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -8,943 | -8,915 | -7,915 | -8,996 |
| Depreciation & Amortization | 1,229 | 1,242 | 545.39 | 386.3 |
| Loss (Gain) From Sale of Assets | - | 0.18 | - | 3.14 |
| Loss (Gain) From Sale of Investments | -159.2 | -194.97 | -595.61 | 380.34 |
| Loss (Gain) on Equity Investments | - | - | -545.52 | 444.93 |
| Stock-Based Compensation | 128.37 | 64.12 | 106.87 | 80.15 |
| Provision & Write-off of Bad Debts | 28.11 | 15.53 | -45.25 | 303.51 |
| Other Operating Activities | 758.02 | 804.8 | 1,088 | 2,252 |
| Change in Accounts Receivable | -10.92 | 100.38 | 405.73 | 1,163 |
| Change in Inventory | -27.75 | 240.19 | -417.85 | -1,772 |
| Change in Accounts Payable | 2.61 | -5.13 | -28.99 | -259.43 |
| Change in Unearned Revenue | 12.09 | - | -35.02 | 35.02 |
| Change in Other Net Operating Assets | -280.32 | -689 | -373.46 | -438.07 |
| Operating Cash Flow | -7,263 | -7,337 | -7,812 | -6,417 |
| Capital Expenditures | -345.08 | -258.73 | -362.85 | -238.43 |
| Sale of Property, Plant & Equipment | - | 0.55 | - | - |
| Cash Acquisitions | - | - | 56.11 | - |
| Sale (Purchase) of Intangibles | -160.48 | -102.37 | -55.96 | -86.86 |
| Investment in Securities | 2,985 | 5,839 | 1,274 | -2,260 |
| Other Investing Activities | 126.03 | 94.06 | 3.25 | 20.68 |
| Investing Cash Flow | 2,606 | 5,572 | -85.42 | -2,565 |
| Long-Term Debt Repaid | - | -405.76 | -88.07 | -71.34 |
| Net Debt Issued (Repaid) | -659.17 | -405.76 | -88.07 | -71.34 |
| Issuance of Common Stock | 160.33 | 211.57 | 242.47 | 224.33 |
| Repurchase of Common Stock | - | -1,518 | - | - |
| Other Financing Activities | 11.92 | -4.31 | 24.07 | 28.32 |
| Financing Cash Flow | -486.92 | -1,716 | 178.48 | 181.32 |
| Foreign Exchange Rate Adjustments | 8.85 | 14.15 | -28.68 | 6.32 |
| Miscellaneous Cash Flow Adjustments | - | 0 | - | 0 |
| Net Cash Flow | -5,135 | -3,467 | -7,747 | -8,794 |
| Free Cash Flow | -7,608 | -7,595 | -8,174 | -6,655 |
| Free Cash Flow Margin | -2202.73% | -628.89% | -911.27% | -182.18% |
| Free Cash Flow Per Share | -1117.08 | -1109.62 | -1176.31 | -964.32 |
| Cash Interest Paid | 139.96 | 137.96 | 133.93 | 95.06 |
| Cash Income Tax Paid | - | -24.3 | 47.01 | 64.87 |
| Levered Free Cash Flow | -4,521 | -1,423 | -8,402 | - |
| Unlevered Free Cash Flow | -4,442 | -1,338 | -8,319 | - |
| Change in Working Capital | -304.28 | -353.55 | -449.58 | -1,272 |
Source: S&P Capital IQ. Standard template. Financial Sources.